Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pregabalin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110803994B reveals a green DES-based route for pregabalin intermediates. Discover how this technology enables cost reduction in API manufacturing and reliable supply.
Patent CN110803993B reveals a green DES-based synthesis for pregabalin intermediates, offering high yields, recyclable solvents, and scalable mechanochemical processing for cost-effective manufacturing.
Patent CN104086439A offers green recovery for pregabalin intermediates reducing waste and cost for reliable pharmaceutical intermediates supplier partnerships.
Novel isovaleraldehyde route enhances purity and yield. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel vanadium-catalyzed route offers high purity pregabalin. Reduces steps and improves yield for reliable API intermediate supplier.
Patent CN108715881B reveals a dual-enzyme route for pregabalin intermediates. Achieve 99.5% e.e. and simplified processing for cost-effective API manufacturing.
Patent CN104193635A offers high-purity pregabalin synthesis via Hofmann degradation ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN104557583A reveals green quinidine catalysis for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability.
Patent CN112359036B discloses engineered nitrilase mutants for efficient synthesis of pregabalin chiral intermediates, offering significant cost reduction in API manufacturing.
Patent CN101585778A details a scalable route from S-(+)-leucine avoiding toxic azides. Ideal for reliable lyrica intermediate supplier sourcing and cost reduction.
Novel metal halide catalysis eliminates high-pressure hydrogenation risks. Delivers high-purity lactam compounds with significant cost reduction in API manufacturing and enhanced supply chain reliability for global partners.
Patent CN108456143A details a high-yield asymmetric route for Pregabalin intermediates ensuring supply chain stability and significant cost reduction for global pharmaceutical manufacturing.
Patent CN113804805A details a solvent-free method for synthesizing Pregabalin Impurity II. Achieve >99% purity for QC standards with reduced environmental impact.
Patent CN101848905A details a novel enantioselective route for (S)-pregabalin using D-mannitol, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN109851543B reveals a cost-effective route for S-pregabalin lactam using acidic oxides. Achieve >99% purity for pharmaceutical impurity standards.
Patent CN103073443B details a novel asymmetric synthesis for Pregabalin, offering improved yield and scalability for pharmaceutical supply chains.
Advanced asymmetric synthesis of pregabalin via CN103073443B. Offers cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain solutions.
Patent CN103626668B reveals a novel resolution method for S-Pregabalin offering high purity and scalable supply chain advantages for pharmaceutical manufacturers.
Advanced chiral synthesis of pregabalin via dibenzylamine intermediates. Reduces genotoxic risks and improves scalability for reliable API manufacturing supply chains.